Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages)

Document first published:
Page updated:
Topic:
Publication type:

This policy statement is to confirm that pazopanib is not recommended as a treatment option for inoperable and metastatic malignant granular cell tumours (all ages).

Document

Policy Statement: Pazopanib for inoperable and metastatic malignant granular cell tumour

Policy Statement: Pazopanib for inoperable and metastatic malignant granular cell tumour

  • PDF
  • 61 KB
  • 3 pages

Document

Pazopanib for inoperable and metastatic malignant granular cell tumour: Engagement Report

Pazopanib for inoperable and metastatic malignant granular cell tumour: Engagement Report

  • PDF
  • 58 KB
  • 3 pages

Document

Pazopanib for inoperable and metastatic malignant granular cell tumour: CPAG Summary Report

Pazopanib for inoperable and metastatic malignant granular cell tumour: CPAG Summary Report

  • PDF
  • 51 KB
  • 4 pages

Document

Pazopanib for inoperable and metastatic malignant granular cell tumour: Clinical Panel Report

Pazopanib for inoperable and metastatic malignant granular cell tumour: Clinical Panel Report

  • PDF
  • 87 KB
  • 2 pages